Switch from cinacalcet to evocalcet in haemodialysis patients in the real world

Switch from cinacalcet to evocalcet in haemodialysis patients in the real world - Switch from cinacalcet to evocalcet in haemodialysis patients in the real world

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058768

Enrollment

8800

Registered

2025-08-18

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese Dialysis Patients with CKD-MBD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients attending a dialysis facility as outpatients who agree to participate in the study

Exclusion criteria

Exclusion criteria: Patients on peritoneal dialysis

Design outcomes

Primary

Measure	Time frame
The primary outcome was achieving an intact PTH below 300 pg/mL on a monthly basis.	—

Countries

Japan

Contacts

Public ContactKoji Kabaya

Patient Driven Academic League Administrative Division

admin@pedal.or.jp075-777-1261

Outcome results